1. Fu, Denggang, Zhang, Biyu, Wu, Shiyong, Ning, Wangbin, Jiang, Hua. 2021. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature. In Frontiers in immunology, 12, 695865. doi:10.3389/fimmu.2021.695865. https://pubmed.ncbi.nlm.nih.gov/34135913/
2. Liu, Xuchen, Zhao, Jiangli, Sun, Qingyuan, Wang, Jiwei, Wang, Xinyu. 2025. Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway. In Theranostics, 15, 2624-2648. doi:10.7150/thno.105591. https://pubmed.ncbi.nlm.nih.gov/39990231/
3. Wilson, Alexa, McCormick, Craig. 2024. Reticulophagy and viral infection. In Autophagy, 21, 3-20. doi:10.1080/15548627.2024.2414424. https://pubmed.ncbi.nlm.nih.gov/39394962/
4. Zheng, Jinxiu, Yang, Ting, Gao, Shuhua, Yang, Lijun, Yang, Tao. . miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8+ T cell-mediated immune attack in colorectal cancer. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21776. doi:10.1096/fj.202100235R. https://pubmed.ncbi.nlm.nih.gov/34324740/
5. Chang, Jiang, Yang, Qingzhuang, Liu, Xiangwei, Li, Wang, Gao, Lianghui. 2024. Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX. In Oncology letters, 28, 474. doi:10.3892/ol.2024.14607. https://pubmed.ncbi.nlm.nih.gov/39161338/
6. Wang, Wenxia, Shi, Yinmin, Yan, Bo, Wang, Liang, Wang, Huijuan. 2024. The dual role of calnexin on malignant progression and tumor microenvironment in glioma. In Scientific reports, 14, 30796. doi:10.1038/s41598-024-81192-6. https://pubmed.ncbi.nlm.nih.gov/39730581/